DossierENTITY

Drugs Controller General of India

Coverage of Drugs Controller General of India in the Nexus archive.

Earliest in view: May 12 · 13:25 UTCMost recent: May 12 · 13:25 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHMay 12 · 13:25 UTCSTAT NEWS
STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and more
17 pharmaceutical companies spent over $130 million on federal lobbying in 2025, a 23% surge, as the TrumpRx prescription drug-pricing program was being shaped. Eli Lilly paused its obesity awareness campaign in India after the nation's drugs regulator warned of potential rule violations. The campaign aimed to reframe obesity as a chronic disease.